Fairmount Funds Management as of Sept. 30, 2024
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 15 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 17.2 | $212M | 2.4M | 89.87 | |
| Nuvalent Inc-a (NUVL) | 14.0 | $173M | 1.7M | 102.30 | |
| Apogee Therapeutics (APGE) | 9.8 | $120M | 2.0M | 58.74 | |
| Spyre Therapeutics Com New (SYRE) | 9.6 | $118M | 4.0M | 29.41 | |
| Enliven Therapeutics (ELVN) | 6.6 | $82M | 3.2M | 25.54 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 6.5 | $80M | 3.2M | 24.99 | |
| Oruka Therapeutics | 6.4 | $79M | 3.2M | 24.51 | |
| Miragen Therapeutics (VRDN) | 6.4 | $78M | 3.4M | 22.75 | |
| Dianthus Therapeutics (DNTH) | 6.0 | $74M | 2.7M | 27.38 | |
| Cogent Biosciences (COGT) | 5.5 | $67M | 6.2M | 10.80 | |
| Day One Biopharmaceuticals I (DAWN) | 3.5 | $43M | 3.1M | 13.93 | |
| Astria Therapeutics (ATXS) | 3.2 | $39M | 3.6M | 11.01 | |
| Bicara Therapeutics | 2.7 | $33M | 1.3M | 25.47 | |
| Zenas Biopharma | 2.6 | $32M | 1.9M | 16.92 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.2 | $2.8M | 124k | 22.63 |
